{"entity":{"type":"insider","cik":"0001255856","url":"/insider/0001255856","json_url":"/insider/0001255856.json","name":"BAILEY MICHAEL P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":9,"first":"2007-07-13","last":"2021-09-03","span_basis":"filed_date"},"name_variants":[{"name":"BAILEY MICHAEL P","source":"filing","n_filings":9,"first_seen":"2007-07-13","last_seen":"2021-09-03"}],"transactions":[{"id":5431810,"accession":"0000899243-21-035140","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-035140","line_url":"/filing/0000899243-21-035140#line-1","is_derivative":false,"issuer_cik":"0001255856","issuer_name":"AVEO PHARMACEUTICALS, INC.","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001255856","owner_cik":"0001255856","owner_name":"BAILEY MICHAEL P","owner_display_name":"BAILEY MICHAEL P","owner_url":"/insider/0001255856","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":6.48,"price_display":"6.48","price_state":"stated","total_value":97200.0,"total_display":"97,200.00","total_whole":"97,200","shares_owned_after":49311.0,"shares_owned_after_display":"49,311","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-01","filed_date":"2021-09-03","scope":"insider"},{"id":7967354,"accession":"0000899243-19-028068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-028068","line_url":"/filing/0000899243-19-028068#line-1","is_derivative":false,"issuer_cik":"0001255856","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001255856","owner_cik":"0001255856","owner_name":"BAILEY MICHAEL P","owner_display_name":"BAILEY MICHAEL P","owner_url":"/insider/0001255856","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":0.5973,"price_display":"0.60","price_state":"stated","total_value":89595.0,"total_display":"89,595.00","total_whole":"89,595","shares_owned_after":318848.0,"shares_owned_after_display":"318,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-21","filed_date":"2019-11-25","scope":"insider"},{"id":8285350,"accession":"0001209191-15-003151","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-003151","line_url":"/filing/0001209191-15-003151#line-2","is_derivative":false,"issuer_cik":"0001255856","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001255856","owner_cik":"0001255856","owner_name":"BAILEY MICHAEL P","owner_display_name":"BAILEY MICHAEL P","owner_url":"/insider/0001255856","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4484.0,"shares_display":"4,484","price_per_share":0.8003,"price_display":"0.80","price_state":"stated","total_value":3588.5452,"total_display":"3,588.55","total_whole":"3,589","shares_owned_after":17035.0,"shares_owned_after_display":"17,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-07","filed_date":"2015-01-08","scope":"insider"},{"id":6749050,"accession":"0001181431-14-004415","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-004415","line_url":"/filing/0001181431-14-004415#line-2","is_derivative":false,"issuer_cik":"0001255856","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001255856","owner_cik":"0001255856","owner_name":"BAILEY MICHAEL P","owner_display_name":"BAILEY MICHAEL P","owner_url":"/insider/0001255856","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5430.0,"shares_display":"5,430","price_per_share":1.6435,"price_display":"1.64","price_state":"stated","total_value":8924.205,"total_display":"8,924.20","total_whole":"8,924","shares_owned_after":34719.0,"shares_owned_after_display":"34,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-30","filed_date":"2014-01-30","scope":"insider"},{"id":4327618,"accession":"0001181431-13-005182","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-005182","line_url":"/filing/0001181431-13-005182#line-2","is_derivative":false,"issuer_cik":"0001255856","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001255856","owner_cik":"0001255856","owner_name":"BAILEY MICHAEL P","owner_display_name":"BAILEY MICHAEL P","owner_url":"/insider/0001255856","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":767.0,"shares_display":"767","price_per_share":7.7711,"price_display":"7.77","price_state":"stated","total_value":5960.4337,"total_display":"5,960.43","total_whole":"5,960","shares_owned_after":64049.0,"shares_owned_after_display":"64,049","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-28","filed_date":"2013-01-28","scope":"insider"},{"id":3411706,"accession":"0001181431-12-004438","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-004438","line_url":"/filing/0001181431-12-004438#line-1","is_derivative":false,"issuer_cik":"0001255856","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001255856","owner_cik":"0001255856","owner_name":"BAILEY MICHAEL P","owner_display_name":"BAILEY MICHAEL P","owner_url":"/insider/0001255856","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":738.0,"shares_display":"738","price_per_share":13.3658,"price_display":"13.37","price_state":"stated","total_value":9863.9604,"total_display":"9,863.96","total_whole":"9,864","shares_owned_after":4116.0,"shares_owned_after_display":"4,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-26","filed_date":"2012-01-30","scope":"insider"},{"id":7232169,"accession":"0001179110-10-012336","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-10-012336","line_url":"/filing/0001179110-10-012336#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"SYNTA PHARMACEUTICALS CORP","issuer_ticker":"SNTA","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001255856","owner_name":"BAILEY MICHAEL P","owner_display_name":"BAILEY MICHAEL P","owner_url":"/insider/0001255856","role":"Officer (Sr. VP, Chief Comm. Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Chief Comm. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Chief Comm. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":3.21,"price_display":"3.21","price_state":"stated","total_value":12840.0,"total_display":"12,840.00","total_whole":"12,840","shares_owned_after":29627.0,"shares_owned_after_display":"29,627","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-05","filed_date":"2010-08-06","scope":"insider"},{"id":3626234,"accession":"0001104659-08-049256","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-08-049256","line_url":"/filing/0001104659-08-049256#line-1","is_derivative":false,"issuer_cik":"0000765258","issuer_name":"IMCLONE SYSTEMS INC","issuer_ticker":"IMCL","issuer_name_source":null,"issuer_url":"/issuer/0000765258","owner_cik":"0001255856","owner_name":"BAILEY MICHAEL P","owner_display_name":"BAILEY MICHAEL P","owner_url":"/insider/0001255856","role":"Officer (SVP, Commercial Ops)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Ops","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14750.0,"shares_display":"14,750","price_per_share":64.1553,"price_display":"64.16","price_state":"stated","total_value":946290.675,"total_display":"946,290.68","total_whole":"946,291","shares_owned_after":2030.0,"shares_owned_after_display":"2,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-19","filed_date":"2008-08-01","scope":"insider"},{"id":8564584,"accession":"0001104659-07-053890","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-07-053890","line_url":"/filing/0001104659-07-053890#line-2","is_derivative":false,"issuer_cik":"0000765258","issuer_name":"IMCLONE SYSTEMS INC","issuer_ticker":"IMCL","issuer_name_source":null,"issuer_url":"/issuer/0000765258","owner_cik":"0001255856","owner_name":"BAILEY MICHAEL P","owner_display_name":"BAILEY MICHAEL P","owner_url":"/insider/0001255856","role":"Officer (SVP, Commercial Ops)","role_mark":"O","role_mark_label":"Officer (SVP, Commercial Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Commercial Ops","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":34.2,"price_display":"34.20","price_state":"stated","total_value":42750.0,"total_display":"42,750.00","total_whole":"42,750","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-07-12","filed_date":"2007-07-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001325879","name":"AVEO PHARMACEUTICALS, INC.","url":"/issuer/0001325879","role":"Director, Officer (President & CEO)","n_filings":6,"first_seen":"2012-01-30","last_seen":"2021-09-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001157601","name":"SYNTA PHARMACEUTICALS CORP","url":"/issuer/0001157601","role":"Officer (Sr. VP, Chief Comm. Officer)","n_filings":1,"first_seen":"2010-08-06","last_seen":"2010-08-06"},{"type":"issuer","type_label":"ISSUER","cik":"0000765258","name":"IMCLONE SYSTEMS INC","url":"/issuer/0000765258","role":"Officer (SVP, Commercial Ops)","n_filings":2,"first_seen":"2007-07-13","last_seen":"2008-08-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001255856","retrieved_at":"2026-08-27T03:03:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}